Erin Johnstone

Eradigm works with select biopharmaceutical companies to develop a deeper and more nuanced understanding of their markets. We focus on informing and shaping high impact strategies for your product or portfolio, whatever its stage in the clinical or commercial life-cycle. Our core expertise is built on decades of experience in the pharmaceutical sector, giving us the ability to deliver value to our clients at the intersection of three key industry dynamics: the ever increasing value imperative, shrinking sources of true competitive advantage and cutting edge therapeutic innovation. Our founding team’s experience spans more than 30 years both leading and supporting the development and commercialisation of some of the world’s most lucrative and innovative biopharmaceutical products.